Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis

Fertility and Sterility

Volumn 93, Issue 2, 2010, Pages 428-436

  Jee, Byung Chul ^a   Suh, Chang Suk ^a,b   Kim, Seok Hyun ^b   Kim, Yong Beom ^a   Moon, Shin Yong ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Estradiol; GnRH agonist; GnRH antagonist; in vitro fertilization; luteal phase

Indexed keywords

ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; NORGESTREL; PROGESTERONE;

ARTICLE; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG EFFECT; ECTOPIC PREGNANCY; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; INDUCED ABORTION; META ANALYSIS; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; HUMANS; LUTEAL PHASE; OVARY; PATIENT SELECTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; TREATMENT OUTCOME;

EID: 74449083900     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.033     Document Type: Article

References (52)

1. Kolibianakis E.M., and Devroey P. The luteal phase after ovarian stimulation. Reprod Biomed Online 5 (2002) 26-35
2. Pabuccu R., and Akar M.E. Luteal phase support in assisted reproductive technology. Curr Opin Obstet Gynecol 17 (2005) 277-281
3. Pritts E.A., and Atwood A.K. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 17 (2002) 2287-2299
4. Daya S., and Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev 3 (2004) CD004830
5. Nosarka S., Kruger T., Siebert I., and Grove D. Luteal phase support in in vitro fertilization: meta-analysis of randomized trials. Gynecol Obstet Invest 60 (2005) 67-74
6. Ludwig M., and Diedrich K. Evaluation of an optimal luteal phase support protocol in IVF. Acta Obstet Gynecol Scand 80 (2001) 452-466
7. Levine H. Luteal support in IVF using the novel vaginal progesterone gel Crinone 8%: results of an open-label trial in 1184 women from 16 US centers. Fertil Steril 74 (2000) 836-837
8. Penzias A. Luteal phase support. Fertil Steril 77 (2002) 318-323
9. Fatemi H.M., Popovic-Todorovic B., Papanikolaou E., Donoso P., and Devroey P. An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update 13 (2007) 581-590
10. Smitz J., Devroey P., Braeckmans P., Camus M., Khan L., Staessen C., et al. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and hMG. Hum Reprod 2 (1987) 309-314
11. Smitz J., Bourgain C., Van Waesberghe L., Camus M., Devroey P., and Van Steirteghem A.C. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and hMG induced superovulation. Hum Reprod 8 (1993) 40-45
12. Lewin A., Benshushan A., Mezker E., Yanai N., Schenker J.G., and Goshen R. The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support. Fertil Steril 62 (1994) 121-125
13. Zegers-Hochschild F., and Altieri E. Luteal estrogen is not required for the establishment of pregnancy in the human. J Assist Reprod Genet 12 (1995) 224-228
14. Gleicher N., Brown T., Dudkiewicz A., Karande V., Rao R., Balin M., et al. Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles-but only in younger women. Early Pregnancy 4 (2000) 64-73
15. Kaider A.S., and Coulam C.B. Luteal estrogen supplementation in pregnancies associated with low serum estradiol concentrations. Early Pregnancy 4 (2000) 191-199
16. Farhi J., Weissman A., Steinfeld Z., Shorer M., Nahum H., and Levran D. Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 73 (2000) 761-766
17. Tay P.Y., and Lenton E.A. Inhibition of progesterone secretion by oestradiol administered in the luteal phase of assisted conception cycles. Med J Malaysia 58 (2003) 187-195
18. Rashidi B.H., Asheghan H., Jafarabadi M., and Tehrani Nejad E. The role of estrogen supplementation during the luteal phase in in vitro fertilization-embryo transfer cycles: a comparative study between progesterone alone and estrogen plus progesterone support. Int Congress Ser 1271 (2004) 120-123
19. Paredes Chávez F.C., Barros Delgadillo J.C., Ochoa Rueda S.S., Barroso Villa G., Villalobos Acosta S., Sánchez Solís V., et al. Estrogen role in the luteal phase support in in vitro fertilization with embryo transfer cycles. Ginecol Obstet Mex 72 (2004) 645-655
20. Gorkemli H., Ak D., Akyurek C., Aktan M., and Duman S. Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles. Gynecol Obstet Invest 58 (2004) 140-144
21. Lukaszuk K., Liss J., Lukaszuk M., and Maj B. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 83 (2005) 1372-1376
22. Drakakis P., Loutradis D., Vomvolaki E., Stefanidis K., Kiapekou E., Anagnostou E., et al. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer. Gynecol Endocrinol 23 (2007) 645-652
23. Engmann L., DiLuigi A., Schmidt D., Benadiva C., Maier D., and Nulsen J. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Fertil Steril 89 (2008) 554-561
24. Serna J., Cholquevilque J.L., Cela V., Martínez-Salazar J., Requena A., and Garcia-Velasco J.A. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial. Fertil Steril 90 (2008) 2190-2195
25. Ceyhan S.T., Basaran M., Kemal Duru N., Yilmaz A., Göktolga U., and Baser I. Use of luteal estrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study. Fertil Steril 89 (2008) 1827-1830
26. Gelbaya T.A., Kyrgiou M., Tsoumpou I., and Nardo L.G. The use of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection cycles: a systematic review and meta-analysis. Fertil Steril 90 (2008) 2116-2125
27. Kolibianakis E.M., Venetis C.A., Papanikolaou E.G., Diedrich K., Tarlatzis B.C., and Griesinger G. Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and meta-analysis. Hum Reprod 23 (2008) 1346-1354
28. Fatemi H.M., Kolibianakis E.M., Camus M., Tournaye H., Donoso P., Papanikolaou E., et al. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod 21 (2006) 2628-2632
29. Farhi J., Steinfeld Z., Shorer M., Nahum H., Weissman A., Glezerman M., et al. Estrogen supplementation during luteal phase improves pregnancy rate in IVF-ET. Fertil Steril 72 (1999) S161
30. Engmann L., Diluigi A., Schmidt D., Benadiva C., Maier D., and Nulsen J. A prospective randomized trial evaluating the effect of luteal phase estradiol supplementation on the success of IVF treatment. Fertil Steril 84 (2005) S88
31. Fatemi H.M., Kolibianakis E.M., Camus M., Tournaye H., Van Steirteghem A., and Devroey P. Progesterone versus progesterone combined with estradiol as luteal support in cycles stimulated with GnRH antagonist/rec-FSH for IVF: a randomized clinical trial. Fertil Steril 84 (2005) S322
32. Liss J., Lukaszuk K., Lukaszuk M., Maj B., and Lukaszuk K. Increase of the pregnancy rate by the estradiol supplementation during the luteal phase in IVF-ET cycles. Hum Reprod 20 (2005) i20
33. Pouly J.L., Piekrishvili R., Beaume-Brugon F., Schubert B., and Janny L. Luteal phase supplementation with oestrogens does not improve the IVF pregnancy rate: a randomized study. Hum Reprod 20 (2005) i72
34. Karlikaya G., Karagozoglu H., Kumbak B., Lacin S., Guney A., and Kahraman S. Adding estradiol to progesteron for luteal phase support does not improve the clinical outcome in assisted reproductive technologies (ART) cycles. Fertil Steril 86 (2006) S112
35. Serna J., Cholquevilque J.L., Villasante A., Oriol B., Requena A., and García-Velasco J. Adding estradiol patches to the luteal phase of IVI/ICSI cycles did not improve pregnancy nor miscarriage rates. Fertil Steril 86 (2006) S73
36. Fauser B.C., and Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab 14 (2003) 236-242
37. Beckers N.G., Macklon N.S., Eijkemans M.J., Ludwig M., Felberbaum R.E., Diedrich K., et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 88 (2003) 4186-4192
38. Kolibianakis E.M., Bourgain C., Platteau P., Albano C., Van Steirteghem A.C., and Devroey P. Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 80 (2003) 464-466
39. Tavaniotou A., and Devroey P. Luteal hormone profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. Reprod Biomed Online 13 (2006) 326-330
40. Friedler S., Gilboa S., Schachter M., Raziel A., Strassburger D., and Ron El R. Luteal phase characteristics following GnRH antagonist or agonist treatment-a comparative study. Reprod Biomed Online 12 (2006) 27-32
41. De Ziegler D., Bergeron C., Cornel C., Medalie D.A., Massai M.R., Milgrom E., et al. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins. J Clin Endocrinol Metab 74 (1992) 322-331
42. Younis S., Ezra Y., Sherman Y., Simon A., Schencker G., and Laufer N. The effect of estradiol depletion during the luteal phase on endometrium development. Fertil Steril 62 (1994) 103-107
43. Fatemi H.M., Camus M., Kolibianakis E.M., Tournaye H., Papanikolaou E.G., Donoso P., et al. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fertil Steril 87 (2007) 504-508
44. Hubayter Z.R., Vlahos N.F., Lai T.H., Garcia J.A., and Zhao Y. The impact of luteal phase support on endometrial estrogen and progesterone receptor expression: a prospective randomized study. Fertil Steril 90 (2008) S65
45. Sharara F.I., and McClamrock H.D. Ratio of estradiol concentration on the day of human chorionic gonadotropin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome. Hum Reprod 14 (1999) 2777-2782
46. Ng E.H.Y., Yeung W.S.B., Lau E.Y.L., So W.W.K., and Ho P.C. A rapid decline in serum estradiol concentrations around the mid-luteal phase had no adverse effect on outcome in 763 assisted reproduction cycles. Hum Reprod 15 (2000) 1903-1908
47. Maximovich A., Stahler M.S., Keye Jr. W.R., and Brinton D.A. In vitro fertilization (IVF) pregnancy rate and luteal phase estradiol level. Fertil Steril 74 (2000) S156
48. 2) and progesterone (P) profiles differ between conception and nonconception in-vitro fertilization-embryo transfer (IVF-ET) cycles utilizing pituitary down-regulation. Fertil Steril 76 (2001) S252-S253
49. Akman M.A., Erden H.F., Bener F., Liu J.E., and Bahceci M. Can luteal phase estradiol levels predict the pregnancy outcome in in vitro fertilization cycles of good responders whose excess embryos yield blastocysts?. Fertil Steril 77 (2002) 638-639
50. Friedler S., Zimerman A., Schachter M., Raziel A., Strassburger D., and Ron El R. The midluteal decline in serum estradiol levels is drastic but not deleterious for implantation after in vitro fertilization and embryo transfer in patients with normal or high responses. Fertil Steril 83 (2005) 54-60
51. Ganesh A, Goswami S, Chattopadhyay R, Chakraborty C, Chaudhury K, Chakravarty BN. Luteal phase estradiol level: a potential predictive marker for successful pregnancy in in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. Published online June 18, 2008 [Epub ahead of print].
52. Hubayter Z.R., and Muasher S.J. Luteal supplementation in in vitro fertilization: more questions than answers. Fertil Steril 89 (2008) 749-758